Clinical Trials Browser

Has results × Central Nervous System Neoplasms × Bortezomib × Clear all

NCT00998010 2020-08-28

Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Phase 2 Completed

24 enrolled 10 charts

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00990652 2014-01-13

Presurgery Bortezomib for Recurrent Malignant Gliomas Followed by Postop Bortezomib & Temozolomide

Phase 2 Completed

10 enrolled 8 charts

Brain Neoplasms, Central Nervous System Neoplasms

NCT00512798 2012-10-02

Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma

Phase 1/2 Terminated

47 enrolled 9 charts

CNSDermatologic

Brain Neoplasms, Melanoma, Central Nervous System Neoplasms